Could a slight oxygen change save preemie lungs?
NCT ID NCT07235345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving a lung treatment (surfactant) at a lower oxygen level helps very premature babies (born before 32 weeks) breathe better. Researchers will compare two oxygen thresholds (25% vs 30%) to see which leads to less time on breathing machines and fewer complications. The goal is to find the best timing for this common therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pulmonary surfactant
- What this could lead to
- If successful, this could lead to a safer, more effective way to give lung treatment to very premature babies, potentially reducing their time on breathing machines.
- What could go wrong
- This is a mid-stage study with 500 babies, but it only compares two oxygen thresholds, not a new drug. The results may not apply to all preterm infants or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Affiliated Hospital of Zhengzhou University
Henan, Zhengzhou, 455000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.